Does smoking cessation with varenicline worsen vascular endothelial function?

OBJECTIVES: A meta-analysis suggested that the use of varenicline, which is a partial agonist of nicotinic acetylcholine receptors and is effective in smoking cessation, increases the risk of cardiovascular events within 52 weeks of starting treatment. Defining these events as occurring during drug...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Umeda, Akira, Kato, Toru, Yamane, Tateki, Yano, Heiichi, Ieiri, Tamio, Miyagawa, Kazuya, Takeda, Hiroshi, Okada, Yasumasa
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2013
Ämnen:
Smoking and Tobacco
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3693419/
https://ncbi.nlm.nih.gov/pubmed/23794597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2013-003052
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk